Gerald Batist is Director of the McGill Centre for Translational Research in Cancer and of the Segal Cancer Centre, Jewish General Hospital.

Dr. Gerald Batist was born in Montreal, and though he was at University in New York City, he returned for medical school at McGill University. This was followed by post-doctoral training in New York, Boston and finally at the National Cancer Institute in Washington. There he trained in medical oncology and in molecular pharmacology.

Dr. Batist is a clinician-scientist, trained in medical oncology and molecular pharmacology. His work, both in his lab and clinical research focuses on therapeutic resistance, focusing on Keap1 somatic mutations. This includes large consortia that run large-scale biopsy-based clinical trials to identify novel mechanisms of resistance to specific drugs. In 2014 he co-led a successful application that resulted in the establishment of the Canadian National Centre of Excellence in Personalized Medicine, Exactis Innovations, which is building a multi-thousand patient cancer trajectory database. In 2016, Dr Batist was appointed Member of the Order of Canada and Knight of the National Order of Quebec, and this year, 2025 was given the King Charles III Coronation Medal for his contributions to Canadian science.